SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: lindalib who wrote (5554)2/10/2015 3:00:27 PM
From: Gary Mohilner  Respond to of 5665
 
I think you've made a good move. I know of no other company with the pipeline of IMGN with a market cap this low. Later this year many of the drugs in that pipeline should reveal results and most, if not all, will justify moving to higher level trials when sufficient data's been taken to do so.

Gary


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News